Publication:
The Protective Effect of Melatonin Against Age-Associated, Sarcopenia-Dependent Tubular Aggregate Formation, Lactate Depletion, and Mitochondrial Changes.

dc.contributor.authorSayed, Ramy K A
dc.contributor.authorFernández-Ortiz, Marisol
dc.contributor.authorDiaz-Casado, María E
dc.contributor.authorRusanova, Iryna
dc.contributor.authorRahim, Ibtissem
dc.contributor.authorEscames, Germaine
dc.contributor.authorLópez, Luis C
dc.contributor.authorMokhtar, Doaa M
dc.contributor.authorAcuña-Castroviejo, Darío
dc.date.accessioned2023-01-25T10:05:23Z
dc.date.available2023-01-25T10:05:23Z
dc.date.issued2018
dc.description.abstractTo gain insight into the mechanism of sarcopenia and the protective effect of melatonin, the gastrocnemius muscles of young (3-4 months), early-aged (12 months), and old-aged (24 months) wild-type C57BL/6J female mice were examined by magnetic resonance and microscopy. Locomotor activity, lactate production, and nuclear apoptosis were also assessed. The results support the early onset of sarcopenia at 12 months of age, with reduction of muscle fiber number, muscle weight/body weight ratio, lactate, and locomotor activity. Lipid droplet infiltration and autophagosomes were also detected. These changes driven little effects on the early-aged muscle, but they got worse in old-aged animals by the progressive damage of the muscle. Old-aged muscle showed a reduction of the mitochondrial number, a destruction of the mitochondrial cristae, and swelling. Tubular aggregates and nucleic acid fragmentation were the most striking findings in old-aged muscle, reflecting a broad damage with loss of autophagy efficacy. Oral melatonin administration conserved the normal muscular architecture, weight, muscle fiber number, and activity in the old age; it stimulated lactate production, prevented mitochondrial damage and tubular aggregates, and reduced the percentage of apoptotic nuclei in aged muscles. Altogether, gastrocnemius muscle showed age-mediated signs of sarcopenia that were reduced by melatonin treatment.
dc.identifier.doi10.1093/gerona/gly059
dc.identifier.essn1758-535X
dc.identifier.pmid29562315
dc.identifier.unpaywallURLhttps://academic.oup.com/biomedgerontology/article-pdf/73/10/1330/25712019/gly059.pdf
dc.identifier.urihttp://hdl.handle.net/10668/12258
dc.issue.number10
dc.journal.titleThe journals of gerontology. Series A, Biological sciences and medical sciences
dc.journal.titleabbreviationJ Gerontol A Biol Sci Med Sci
dc.language.isoen
dc.organizationHospital Universitario San Cecilio
dc.organizationHospital Universitario Virgen de las Nieves
dc.page.number1330-1338
dc.pubmedtypeJournal Article
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.rights.accessRightsopen access
dc.subject.meshAging
dc.subject.meshAnimals
dc.subject.meshFemale
dc.subject.meshLactic Acid
dc.subject.meshMagnetic Resonance Imaging
dc.subject.meshMelatonin
dc.subject.meshMice
dc.subject.meshMice, Inbred C57BL
dc.subject.meshMicroscopy, Electron, Transmission
dc.subject.meshMitochondria, Muscle
dc.subject.meshMotor Activity
dc.subject.meshMuscle Fibers, Skeletal
dc.subject.meshMuscle, Skeletal
dc.subject.meshProtective Agents
dc.subject.meshSarcopenia
dc.titleThe Protective Effect of Melatonin Against Age-Associated, Sarcopenia-Dependent Tubular Aggregate Formation, Lactate Depletion, and Mitochondrial Changes.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number73
dspace.entity.typePublication

Files